IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
MIR203A |
|
microRNA 203a
|
|
|
0.471 |
0.808 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
PCM1 |
Q15154
|
pericentriolar material 1
|
|
3.7E-16 |
0.644 |
0.615 |
L3MBTL1 |
Q9Y468
|
L3MBTL histone methyl-lysine binding protein 1
|
Epigenetic regulator
|
1.5E-12 |
0.729 |
0.269 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
ANPEP |
P15144
|
alanyl aminopeptidase, membrane
|
Enzyme
|
3.7E-09 |
0.462 |
0.769 |
ZNRD2 |
O60232
|
zinc ribbon domain containing 2
|
|
1.8E-07 |
0.443 |
0.769 |
PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
PIK3CG |
P48736
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
Kinase
|
1.4E-06 |
0.320 |
0.885 |
NTRK1 |
P04629
|
neurotrophic receptor tyrosine kinase 1
|
Kinase
|
2.0E-06 |
0.422 |
0.808 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
PSMD9 |
O00233
|
proteasome 26S subunit, non-ATPase 9
|
Enzyme modulator
|
4.9E-06 |
0.435 |
0.846 |
JAK3 |
P52333
|
Janus kinase 3
|
Kinase
|
5.9E-06 |
0.505 |
0.731 |
MTTP |
P55157
|
microsomal triglyceride transfer protein
|
Transporter
|
1.0E-05 |
0.505 |
0.846 |
ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
TBC1D9 |
Q6ZT07
|
TBC1 domain family member 9
|
Enzyme
|
2.8E-05 |
0.399 |
0.846 |
HOXA9 |
P31269
|
homeobox A9
|
|
4.4E-05 |
0.521 |
0.692 |
TFRC |
P02786
|
transferrin receptor
|
Enzyme
|
7.0E-05 |
0.437 |
0.885 |